Vaxart, Inc.

Vaxart, Inc. - ROEverified

VXRT

Price:

$0.55

Market Cap:

$133.12M

Vaxart, Inc. operates as a biotechnology firm currently in the clinical development phase, concentrating its efforts on identifying and advancing novel oral recombinant protein vaccines. The company leverages its unique proprietary platform for delivering these oral vaccine solutions. Its diverse pipeline showcases several promising candidates: An oral tablet vaccine targeting norovirus, which is presently undergoing Phase Ib clinical assessment for both GI.1 and GII.4 strains. A seasonal influenza vaccine, now in Phase II clinical studies, designed to address H1 influenza infections. A vaccine candidate against respiratory syncytial virus (RSV). A coronavirus vaccine, also advancing through...[Read more]

Industry

Biotechnology

IPO Date

1981-12-11

Stock Exchange

NASDAQ

Ticker

VXRT

The ROE as of June 2026 (TTM) for Vaxart, Inc. (VXRT) is 61.43%

According to Vaxart, Inc.’s latest financial reports and current stock price. The company's current ROE is 61.43%. This represents a change of -3246.45% compared to the average of -1.95% of the last 4 quarters.

Vaxart, Inc. (VXRT) Historical ROE (quarterly & annually)

How has VXRT ROE performed in the past?

The mean historical ROE of Vaxart, Inc. over the last ten years is -82.80%. The current 61.43% ROE has changed -174.19% with respect to the historical average. Over the past ten years (40 quarters), VXRT's ROE was at its highest in in the December 2025 quarter at 62.70%. The ROE was at its lowest in in the December 2019 quarter at -49.48%.

Quarterly (TTM)
Annual

Average

-82.80%

Median

-105.52%

Minimum

-160.23%

Maximum

32.18%

Vaxart, Inc. (VXRT) ROE by Quarter and Year

Discovering the peaks and valleys of Vaxart, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 185.97%

Maximum Annual ROE = 32.18%

Minimum Annual Increase = -597.96%

Minimum Annual ROE = -160.23%

Quarterly (TTM)
Annual
YearROEChange
202518.60%-116.37%
2024-113.62%-20.36%
2023-142.66%46.42%
2022-97.43%159.28%
2021-37.58%43.92%
2020-26.11%-81.86%
2019-143.95%-10.16%
2018-160.23%-597.96%
201732.18%-120.47%
2017-157.22%185.97%

Vaxart, Inc. (VXRT) Average ROE

How has VXRT ROE performed in the past?

The current ROE of Vaxart, Inc. (VXRT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-79.23%

5-year avg

-74.54%

10-year avg

-82.80%

Vaxart, Inc. (VXRT) ROE vs. Peers

How is VXRT’s ROE compared to its peers?

Vaxart, Inc.’s ROE is greater than Acrivon Therapeutics, Inc. Common Stock (-64.43%), greater than Unicycive Therapeutics, Inc. (-131.18%), greater than CAMP4 Therapeutics Corporation (-194.74%), greater than Immunic, Inc. (-220.75%), greater than PMV Pharmaceuticals, Inc. (-68.98%), greater than Relmada Therapeutics, Inc. (-71.22%), greater than Cibus, Inc. (-225.59%), greater than TScan Therapeutics, Inc. (-91.94%), greater than Repare Therapeutics Inc. (-57.56%), less than Fortress Biotech, Inc. (163.88%),

Build a custom stock screener for Vaxart, Inc. (VXRT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vaxart, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vaxart, Inc. (VXRT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vaxart, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Vaxart, Inc.'s ROE?

How is the ROE calculated for Vaxart, Inc. (VXRT)?

What is the highest ROE for Vaxart, Inc. (VXRT)?

What is the 3-year average ROE for Vaxart, Inc. (VXRT)?

What is the 5-year average ROE for Vaxart, Inc. (VXRT)?

How does the current ROE for Vaxart, Inc. (VXRT) compare to its historical average?